Cipla secures CDSCO approval for Afrezza, its inhaled insulin, marking a breakthrough in diabetes management with innovative ...

The company's lineup also includes other blockbuster drugs with strong momentum. Sales of autoimmune disease drug Taltz, breast cancer drug Verzenio, and fast-acting insulin Humalog soared by 17% or ...